This is the second article in a 6 part series Jim Nortz published on the Corporate Compliance Insights website to provide practical guidance to pharmaceutical and medical device companies about how to avoid significant government enforcement actions. To view the article below, please use the navigation at the bottom of the file.
Jim Nortz, is an attorney and a nationally recognized expert and thought leader in the field of business ethics and compliance. He has over three decades of executive experience at multinational corporations in the petrochemical, staffing, business process outsourcing, medical device, and pharmaceutical industries.